China remains the largest player in Asia for cross border deals, with $7.4bn in total deal value or 85% of the region in 1H 2016.
Tag Archives | China
Cindat Capital Management and Beijing-based life insurer Union Life Insurance have acquired a portfolio of senior housing from REIT Welltower for $930 million.
Bain Capital-owned Asia Pacific Medical Group has sold plastic surgery chain The Sloane Clinic to Singapore-listed China Medical International Group for $9.5 million.
At the China Everbright Investor Conference, FountainVest Partners chief executive Frank Tang highlighted potential deals in healthcare and advanced manufacturing.
Canadian venture capital firm Quark Venture and Chinese investment bank GF Securities have held a first close of $100m on a $500 million life sciences fund.
Government intervention in drug pricing and more stringent regulation is pushing domestic pharmaceutical companies to acquire foreign assets.
Raphael Arndt, the chief investment officer of Australia’s A$122.8 billion Future Fund, said the fund is looking at opportunities in Chinese healthcare.
Private equity firm Primavera Capital and a drug manufacturer have made an offer to acquire Australian health food maker Vitaco.
The transaction marks the first cross-border healthcare deal led by a Chinese strategic into the European market in 2016.
Guangshao Tu, a known reformer who was previously asked to lead the entire organisation, has joined as vice-chairman.